Tomas Leanderson
Corporate Officer/Principal chez University of Lund
Profil
Tomas Leanderson is a Professor of Immunology at the University of Lund, where he has been employed since 1990.
He was previously the President, Co-Chief Executive Officer, and IR Contact at Active Biotech AB from 2008 to 2017.
He also served as a Director at ProNoxis AB.
Leanderson earned a doctorate degree from Umea Universitet.
Postes actifs de Tomas Leanderson
| Sociétés | Poste | Début |
|---|---|---|
| University of Lund | Corporate Officer/Principal | 06/05/2010 |
Anciens postes connus de Tomas Leanderson
| Sociétés | Poste | Fin |
|---|---|---|
| ACTIVE BIOTECH AB | Directeur Général | 01/07/2017 |
ProNoxis AB
 ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Directeur/Membre du Conseil | - |
Formation de Tomas Leanderson
| Umea Universitet | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ACTIVE BIOTECH AB | Health Technology |
| Entreprise privées | 1 |
|---|---|
ProNoxis AB
ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Health Technology |
